UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000039814
Receipt No. R000045379
Scientific Title Randomized comparison of several messages for increasing the rate of hepatitis virus testing
Date of disclosure of the study information 2020/03/15
Last modified on 2020/03/13 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Randomized comparison of several messages for increasing the rate of hepatitis virus testing
Acronym RCT for increasing rate of Hepatitis virus testing
Scientific Title Randomized comparison of several messages for increasing the rate of hepatitis virus testing
Scientific Title:Acronym RCT for increasing rate of Hepatitis virus testing
Region
Japan

Condition
Condition Viral Hepatitis
Classification by specialty
Hepato-biliary-pancreatic medicine Infectious disease Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the effects of leaflets developed for increasing the rate of hepatitis virus testing
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Phase III

Assessment
Primary outcomes Hepatitis virus testing rate
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Active
Stratification YES
Dynamic allocation NO
Institution consideration Institution is considered as a block.
Blocking YES
Concealment Numbered container method

Intervention
No. of arms 3
Purpose of intervention Prevention
Type of intervention
Behavior,custom
Interventions/Control_1 "Fear appeal-Reassuring" type leaflet
Interventions/Control_2 "Barrier removing" type leaflet
Interventions/Control_3 Standard leaflet
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Employees of study partner companies
Key exclusion criteria Those who have experience of hepatitis virus testing
Target sample size 600

Research contact person
Name of lead principal investigator
1st name Seiichiro
Middle name
Last name Yamamoto
Organization National Cancer Center
Division name Center for Cancer Control and Information Services
Zip code 104-0045
Address 5-1-1, Tsukiji, Chuo, Tokyo, Japan 104-0045
TEL 03-3542-2511
Email siyamamo@ncc.go.jp

Public contact
Name of contact person
1st name Seiichiro
Middle name
Last name Yamamoto
Organization National Cancer Center
Division name Center for Cancer Control and Information Services
Zip code 104-0045
Address 5-1-1, Tsukiji, Chuo, Tokyo, Japan 104-0045
TEL 03-3542-2511
Homepage URL
Email siyamamo@ncc.go.jp

Sponsor
Institute National Cancer Center
Institute
Department

Funding Source
Organization National Cancer Center
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Saga University
Name of secondary funder(s)

IRB Contact (For public release)
Organization National Cancer Center
Address 5-1-1, Tsukiji, Chuo, Tokyo, Japan 104-0045
Tel 03-3542-2511
Email irst@ml.res.ncc.go.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 医療法人社団如水会今村病院(佐賀県)

Other administrative information
Date of disclosure of the study information
2020 Year 03 Month 15 Day

Related information
URL releasing protocol Not available
Publication of results Unpublished

Result
URL related to results and publications Study on going
Number of participants that the trial has enrolled 872
Results
On going
Results date posted
2020 Year 03 Month 13 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
2022 Year 12 Month 31 Day
Baseline Characteristics
On going
Participant flow
On going
Adverse events
Not applicable
Outcome measures
On going
Plan to share IPD Shareble
IPD sharing Plan description Will be planned after study finished

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2019 Year 01 Month 21 Day
Date of IRB
2019 Year 01 Month 24 Day
Anticipated trial start date
2019 Year 04 Month 01 Day
Last follow-up date
2020 Year 03 Month 31 Day
Date of closure to data entry
2020 Year 05 Month 31 Day
Date trial data considered complete
2020 Year 08 Month 31 Day
Date analysis concluded
2021 Year 03 Month 31 Day

Other
Other related information

Management information
Registered date
2020 Year 03 Month 13 Day
Last modified on
2020 Year 03 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045379